不少市民有自己泡酒的习惯，比如桑葚酒、梅子酒等，还有的市民在泡酒时会加入各类中药材，比如人 参、当归、黄芪等，尤其是到了冬天更爱喝点自制的小酒。但如果操作不当，就有把自己喝进医院的可 能。近日，记者从重庆大学附属沙坪坝医院获悉，该院最近收治了一名因饮用自制药酒中毒，把自己喝 进ICU的七旬老人。 据介绍，患者李先生今年（化名）年过七旬，他听说用川乌泡酒饮用有养生效果后，在家用10克川乌和 500毫升白酒泡制了药酒。泡制一段时间后，李先生认为可以喝了，于是取了一小杯大约40毫升的药酒 饮用。药酒下肚仅半小时，李先生就开始出现失去意识、四肢颤抖、冒冷汗等症状，家属见状立即拨打 120，紧急送往医院。 李先生入院时情况危急，出现恶性心律失常，血液循环极不稳定，还伴有严重的乳酸中毒，被送入了 ICU。医院重症医学科团队迅速展开抢救，经多学科会诊后，医生团队决定为患者实施静脉——动脉体 外膜肺氧合治疗、血液灌流等治疗。在ICU团队的精心照料下，李先生的病情逐渐稳定，目前已康复出 院。 该院重症医学科主任、主任医师何盛琴表示，自制药酒潜藏着多种风险。 新闻延伸 上游新闻-重庆晨报记者 何艳 哪些药材泡酒会导致中毒 据媒体 ...

Core Viewpoint - Qingdao Beer is acquiring 100% of Jimo Yellow Wine for 665 million yuan to optimize its seasonal losses and diversify its business, leveraging the complementary seasonal sales of beer and yellow wine [1][3][5] Group 1: Acquisition Details - The acquisition price of 6.65 billion yuan represents a premium of over 200% compared to Jimo Yellow Wine's net assets of 203 million yuan [1] - Jimo Yellow Wine reported a revenue of 166 million yuan in 2024, a year-on-year increase of 13.5%, and a net profit of 30.47 million yuan, up 38% [2] Group 2: Market Context - Qingdao Beer has faced declining sales, with a 5.3% drop in revenue to 32.138 billion yuan in 2024, marking the lowest growth rates for net profit since 2017 [5] - The beer industry in China is experiencing a downturn, with a 0.6% decrease in production among major breweries in 2024 [6] Group 3: Strategic Implications - The acquisition aims to address Qingdao Beer’s seasonal losses, as the fourth quarter is a peak season for yellow wine, contrasting with beer's summer peak [3][6] - Analysts express caution regarding the acquisition, highlighting challenges in integrating the two distinct product lines and the need for effective market education for yellow wine [8]